Celebrating America's Patient Advocates: Advancing the Next Era of Innovation and Access

Event Context & Mission

• The Milken Institute hosted a gathering of patient advocates, researchers, and industry leaders to celebrate the 250th anniversary of the U.S. and advance patient-driven innovation.
• The event aimed to move patients from "subjects" to "active partners" in research, policy, and care delivery.
• The culmination of the day involved the drafting of a "Declaration for Patient-Driven Innovation, Access, and Trust" based on interactive table discussions.

Key Financial & Policy Achievements

• ALS Funding: The I Am ALS coalition successfully mobilized $1.6 billion in new federal funding for ALS research.
• Legislation: The "Act for ALS" legislation was reauthorized by the Senate for an additional $500 million just weeks prior to the event.
• Parkinson's Investment: The Michael J. Fox Foundation will fund $700 million in research this year, exceeding the U.S. government's contribution of $255 million; the organization has raised $1.75 billion of a $2.5 billion global campaign.
• Cures for All: A new coalition has been launched by I Am ALS to link arms with Alzheimer's, Parkinson's, and other neurodegenerative disease groups to apply a unified patient-led policy playbook.

Technology, AI, and Data Innovation

• Patient-Led Data: The Crohn's & Colitis Foundation built a research accelerator with 30,000 consented patients; their shared data has reportedly shaved three years off external research timelines.
• AI in Healthcare: 81% of physicians use AI daily, and 32% of Americans have used AI for healthcare data, a figure that doubled from the previous year.
• Synthetic Data: Advocacy groups are utilizing synthetic data and enterprise AI tools to train models without compromising patient privacy, allowing data to influence algorithms while maintaining security.
• Barriers to Access: Panelists highlighted that AI and technology are currently underrepresented in training data for rare diseases, creating a "data gap" that requires patient advocacy groups to contribute specific, high-value datasets.

Strategic Shifts in Advocacy & Collaboration

• From Tokenism to Leadership: Organizations like I Am ALS shifted from token patient involvement to patient-led agenda setting, organizing hundreds of volunteers with campaign-style operations.
• Pharma Partnerships: The National Psoriasis Foundation and Crohn's & Colitis Foundation engaged directly with insurers and pharma to remove barriers like latent TB testing requirements and step therapy, using data to prove value.
• Care Models: Synapticure was launched to democratize neurology care, aiming to reduce wait times from nine months to weeks by connecting patients with subspecialty neurologists virtually.
• Primary Care Integration: The American Academy of Family Physicians is working to democratize knowledge, positioning primary care physicians as the first point of contact for navigating complex systems and accessing new guidelines.

Challenges & Future Priorities

• Funding Uncertainty: Patient organizations identified "sustaining organizational capacity" and "funding certainty" as their top challenges, with many calling for earmarked NIH funds specifically for patient advocacy groups rather than academia.
• Equity & Trust: Trust in healthcare systems remains low; advocates emphasized that trust must be assumed at the start of interactions rather than earned, and that systems must address the "caregiver burden" which can lead to health issues for the caregivers themselves.
• Regulatory & Access Friction: Panelists noted that while drug approvals are increasing, access to care, coverage decisions, and the "last mile" of implementation remain significant bottlenecks.
• Rare Disease Ecosystem: Advocates for rare diseases stressed that without direct funding and control over contracts, they cannot accelerate timelines fast enough to save lives, urging Congress to support patient-led research pipelines.

Audience & Panel Insights

• Core Strengths: Audience polling identified "accelerating research" and "changing public perception" as the top impacts of patient advocates over the last 40 years.
• Storytelling Strategy: Effective advocacy requires "Smart Brevity" (what's new, why it matters) and leveraging authentic personal stories to cut through noise in the "new attention economy."
• Future State Vision: Participants defined a future system where patients are not consulted but are "partners and drivers of change," with progress measured by reduced friction, equitable access, and improved quality of life rather than just clinical endpoints.

Closing Sentiment

• The event concluded with a commitment to avoid "bake sales" for funding, pushing instead for structural changes to ensure patient organizations can lead research and care delivery.
• Personal anecdotes, including the diagnosis of the event's organizer's partner with prostate cancer, underscored the urgency of bridging the gap between innovation and real-world access.